포스파티딜에탄올아민 시장 보고서(2026년)
Phosphatidylethanolamine Global Market Report 2026
상품코드 : 1957651
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,745,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,750,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,755,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

포스파티딜에탄올아민 시장 규모는 최근 현저한 성장을 보이고 있습니다. 2025년 6억 달러에서 2026년에는 6억 4,000만 달러에 이르고, CAGR 7.4%로 성장할 전망입니다. 지금까지의 성장은 막 연구에서의 전통적인 인지질 사용, 콩과 달걀노른자 원료에 대한 의존도, 의약품 첨가제 수요 증가, 화장품 유화제 사용 확대, 식품 첨가물 산업 확대 등이 원인으로 꼽힙니다.

포스파티딜에탄올아민 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 8억 5,000만 달러에 이르고, CAGR은 7.1%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 지질 기반 약물 전달 시스템에 대한 투자 증가, 건강 보조 식품 및 보충제 소비 증가, 지속 가능한 식물성 지질 공급원으로의 전환, 생명공학 연구 활동 확대, 제약 등급 인지질에 대한 규제 승인 증가 등이 있습니다. 예측 기간의 주요 동향으로는 리포좀 기반 약물 전달에 있어 포스파티딜에탄올아민의 사용 증가, 천연 유래 및 식물성 인지질에 대한 수요 증가, 영양 보충제 및 기능성 식품에 대한 적용 확대, 기능성 지질을 이용한 화장품 처방 확대, 세포막 및 생의학 연구 분야에서의 채택 증가 등이 있습니다. 증가 등을 들 수 있습니다.

천연 건강 보조 식품에 대한 수요 증가는 향후 몇 년 동안 포스파티딜에탄올아민 시장의 성장을 견인할 것으로 예측됩니다. 천연 건강보조식품은 천연 유래 성분으로 제조되어 종합적인 건강 유지 및 증진을 목적으로 하는 제품입니다. 건강에 대한 인식이 높아지고 자연적이고 예방적인 의료 접근법에 대한 관심이 높아지면서 천연 건강 보조 식품에 대한 수요가 증가하고 있습니다. 포스파티딜에탄올아민은 뇌 기능 지원, 세포 건강 증진, 지방 대사 보조 등의 효과로 인해 천연 건강 보조 식품에서 가치 있는 성분입니다. 예를 들어, 미국 비영리단체인 미국식물위원회(American Botanical Council)에 따르면, 2024년 9월 기준 미국 내 허브 건강보조식품 소매 매출은 2022년 120억 1,800만 달러에서 2023년 125억 5,100만 달러로 4.4% 증가할 것으로 전망하고 있습니다. 미화로 4.4% 증가했습니다. 따라서, 천연 건강 보조제에 대한 수요 증가는 포스파티딜에탄올아민 시장의 성장을 가속하고 있습니다.

포스파티딜에탄올아민 시장에서 사업을 전개하는 주요 기업들은 첨단 치료 및 화장품 응용 분야에서 막 융합 효율 향상, 약물 전달 성능 강화, 생체 적합성 향상을 목표로 디올레오일 포스파티딜에탄올아민과 같은 혁신적인 제제 개발에 주력하고 있습니다. 디올레오일포스파티딜에탄올아민은 두 개의 올레산 사슬이 포스파티딜에탄올아민 분자에 결합된 합성 인지질로, 막 연구 및 약물 전달 시스템에서 널리 사용되고 있습니다. 예를 들어, 2023년 12월 독일에 본사를 둔 제약회사 리포이드사(Lipoid GmbH)는 에탄올에 빠르고 완전하게 용해되는 새로운 품질 등급의 LIPOID PE 18:1/18:1(DOPE)을 도입하여 고객의 가공 효율 향상에 기여하고 있습니다. 기여하고 있습니다. 이 제품은 생리학적 pH에서 중성쌍성 이온 분자인 리포이드의 포스파티딜에탄올아민 제품군의 일부로, 리포이드가 생산 효율성 향상과 제품 라인의 확장에 지속적으로 주력하고 있음을 보여줍니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

LSH
영문 목차

영문목차

Phosphatidylethanolamine is a type of phospholipid commonly present in biological membranes, where it plays an essential role in preserving membrane structure, fluidity, and cellular signaling. Owing to its structural and functional lipid characteristics, it is used in a range of applications, including cell membrane research, liposome-based drug delivery systems, dietary supplements, and cosmetic formulations.

The main product types in the phosphatidylethanolamine market include powder and liquid forms. Phosphatidylethanolamine in powder form is a dry, solid version of the phospholipid that allows for easy measurement and use in supplements, pharmaceutical products, or cosmetic applications. It is sourced from materials such as soybean, sunflower, egg yolk, marine sources, and canola, and is distributed through multiple channels, including online retail, offline retail, direct sales, as well as distributors and wholesalers. The key end-user industries include healthcare, food processing, cosmetics, animal nutrition, and biotechnology.

Tariffs have impacted the phosphatidylethanolamine market by increasing costs associated with imported raw materials and processed phospholipids derived from soybean, marine, and sunflower sources. Healthcare, cosmetic, and biotechnology segments are particularly affected, with Asia-Pacific and Europe facing notable pricing pressures due to cross-border trade dependencies. These tariffs have led to higher production costs and supply chain restructuring. However, they have also encouraged regional sourcing, local processing capabilities, and innovation in alternative raw material utilization, supporting long-term market resilience.

The phosphatidylethanolamine market research report is one of a series of new reports from The Business Research Company that provides phosphatidylethanolamine market statistics, including phosphatidylethanolamine industry global market size, regional shares, competitors with a phosphatidylethanolamine market share, detailed phosphatidylethanolamine market segments, market trends and opportunities, and any further data you may need to thrive in the phosphatidylethanolamine industry. This phosphatidylethanolamine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The phosphatidylethanolamine market size has grown strongly in recent years. It will grow from $0.6 billion in 2025 to $0.64 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to traditional use of phospholipids in membrane research, reliance on soybean and egg yolk sources, growth in pharmaceutical excipient demand, increasing use in cosmetic emulsifiers, expansion of food additives industry.

The phosphatidylethanolamine market size is expected to see strong growth in the next few years. It will grow to $0.85 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising investment in lipid-based drug delivery systems, growing nutraceutical and dietary supplement consumption, shift toward sustainable and plant-based lipid sources, expansion of biotechnology research activities, increasing regulatory approvals for pharmaceutical-grade phospholipids. Major trends in the forecast period include rising use of phosphatidylethanolamine in liposome-based drug delivery, growing demand for natural and plant-based phospholipids, increased application in dietary supplements and functional foods, expansion of cosmetic formulations using functional lipids, rising adoption in cell membrane and biomedical research.

The rising demand for natural health supplements is anticipated to drive the growth of the phosphatidylethanolamine market in the coming years. Natural health supplements are products derived from natural ingredients that support and enhance overall health. The growing demand for natural health supplements is driven by increasing health awareness and a strong preference for natural, preventive healthcare approaches. Phosphatidylethanolamine is valuable in natural health supplements because it supports brain function, promotes cellular health, and aids fat metabolism. For instance, in September 2024, according to the American Botanical Council, a US-based nonprofit organization, U.S. retail sales of herbal dietary supplements increased to $12.551 billion in 2023 from $12.018 billion in 2022, representing a 4.4% rise. Therefore, the increasing demand for natural health supplements is fueling the growth of the phosphatidylethanolamine market.

Major companies operating in the phosphatidylethanolamine market are concentrating on the development of innovative formulations, such as dioleoylphosphatidylethanolamine, to improve membrane fusion efficiency, enhance drug delivery performance, and increase biocompatibility in advanced therapeutic and cosmetic applications. Dioleoylphosphatidylethanolamine is a synthetic phospholipid consisting of two oleic acid chains linked to a phosphatidylethanolamine molecule and is widely used in membrane studies and drug delivery systems. For example, in December 2023, Lipoid GmbH, a Germany-based pharmaceutical company, introduced a new quality grade of LIPOID PE 18:1/18:1 (DOPE) that allows rapid and complete dissolution in ethanol, improving processing efficiency for customers. This product is part of Lipoid's phosphatidylethanolamine portfolio, which includes neutral zwitterionic molecules at physiological pH, highlighting the company's continued focus on enhancing production efficiency and expanding its product range.

In February 2023, Croda International Plc, a UK-based chemicals company, acquired Solus Biotech Co. Ltd. for an undisclosed amount. Through this acquisition, Croda seeks to reinforce its position in the global beauty and pharmaceutical markets by broadening its portfolio with Solus Biotech's advanced phospholipids, including phosphatidylethanolamine, and ceramides, strengthening its sustainable biotechnology capabilities, expanding its manufacturing footprint in Asia, and accelerating innovation through the establishment of a new regional research and development hub. Solus Biotech Co. Ltd. is a South Korea-based biomaterials company that produces phosphatidylethanolamine.

Major companies operating in the phosphatidylethanolamine market are Avantor Inc., Cayman Chemical, Lipoid GmbH, Enzo Life Sciences Inc., Creative BioStructure Inc., Wako Pure Chemical Industries Ltd., VAV Lipids Pvt Ltd., Creative Biolabs Inc., Simson Pharma Limited, Alfa Chemistry, Lipoid Kosmetik AG, Lipotype GmbH, CLINIVEX PHARMACEUTICALS PRIVATE LIMITED, Otto Chemie Pvt Ltd., AxisPharm LLC, Lecico GmbH, Nutri Avenue Inc., Glentham Life Sciences, CymitQuimica, Shandong Longilat Biotechnology Co. Ltd.

Europe was the largest region in the phosphatidylethanolamine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the phosphatidylethanolamine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the phosphatidylethanolamine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The phosphatidylethanolamine market consists of sales of PE-rhodamine conjugates, synthetic lipid bilayers or lipid standards, skin barrier repair creams, cell culture reagents and lipid nanoparticles, membrane protein reconstitution services, cell imaging and fluorescent labeling services, and artificial membrane synthesis services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Phosphatidylethanolamine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses phosphatidylethanolamine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for phosphatidylethanolamine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The phosphatidylethanolamine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Phosphatidylethanolamine Market Characteristics

3. Phosphatidylethanolamine Market Supply Chain Analysis

4. Global Phosphatidylethanolamine Market Trends And Strategies

5. Phosphatidylethanolamine Market Analysis Of End Use Industries

6. Phosphatidylethanolamine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Phosphatidylethanolamine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Phosphatidylethanolamine Total Addressable Market (TAM) Analysis for the Market

9. Phosphatidylethanolamine Market Segmentation

10. Phosphatidylethanolamine Market Regional And Country Analysis

11. Asia-Pacific Phosphatidylethanolamine Market

12. China Phosphatidylethanolamine Market

13. India Phosphatidylethanolamine Market

14. Japan Phosphatidylethanolamine Market

15. Australia Phosphatidylethanolamine Market

16. Indonesia Phosphatidylethanolamine Market

17. South Korea Phosphatidylethanolamine Market

18. Taiwan Phosphatidylethanolamine Market

19. South East Asia Phosphatidylethanolamine Market

20. Western Europe Phosphatidylethanolamine Market

21. UK Phosphatidylethanolamine Market

22. Germany Phosphatidylethanolamine Market

23. France Phosphatidylethanolamine Market

24. Italy Phosphatidylethanolamine Market

25. Spain Phosphatidylethanolamine Market

26. Eastern Europe Phosphatidylethanolamine Market

27. Russia Phosphatidylethanolamine Market

28. North America Phosphatidylethanolamine Market

29. USA Phosphatidylethanolamine Market

30. Canada Phosphatidylethanolamine Market

31. South America Phosphatidylethanolamine Market

32. Brazil Phosphatidylethanolamine Market

33. Middle East Phosphatidylethanolamine Market

34. Africa Phosphatidylethanolamine Market

35. Phosphatidylethanolamine Market Regulatory and Investment Landscape

36. Phosphatidylethanolamine Market Competitive Landscape And Company Profiles

37. Phosphatidylethanolamine Market Other Major And Innovative Companies

38. Global Phosphatidylethanolamine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Phosphatidylethanolamine Market

40. Phosphatidylethanolamine Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기